A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer-Reference-Cited by-同舟云学术

A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer

Published:2013-09 Issue:3 Volume:130 Page:518-524
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Kim Kenneth H.,Dmitriev Igor P.,Saddekni Souheil,Kashentseva Elena A.,Harris Raymond D.,Aurigemma Rosemarie,Bae Sejong,Singh Karan P.,Siegal Gene P.,Curiel David T.,Alvarez Ronald D.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference31 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Engl J Med,1996

3. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group Study;Ozols;J Clin Oncol,2003

4. Surgery for ovarian cancer: how to improve survival;Bristow;Lancet,2006

5. Intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N Engl J Med,2006

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine targeting to mucosal lymphoid tissues promotes humoral immunity in the gastrointestinal tract;Science Advances;2024-05-31

2. Molecular insights and promise of oncolytic virus based immunotherapy;Advances in Protein Chemistry and Structural Biology;2024

3. Therapeutic Efficacy of Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors for Human Ovarian Cancer;Anticancer Research;2023-11-29

4. Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?;International Immunopharmacology;2023-09

5. Anticancer Activity of Measles–Mumps–Rubella MMR Vaccine Viruses against Glioblastoma;Cancers;2023-08-28